TADDEI, GIAN LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.299
EU - Europa 11.110
AS - Asia 5.437
SA - Sud America 613
AF - Africa 172
OC - Oceania 147
Continente sconosciuto - Info sul continente non disponibili 1
Totale 30.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.186
RU - Federazione Russa 3.055
PL - Polonia 2.685
SG - Singapore 1.592
SE - Svezia 1.287
IT - Italia 1.181
CN - Cina 1.064
HK - Hong Kong 820
IE - Irlanda 742
KR - Corea 636
VN - Vietnam 625
UA - Ucraina 593
BR - Brasile 502
DE - Germania 477
FR - Francia 377
FI - Finlandia 308
GB - Regno Unito 235
AU - Australia 142
IN - India 140
JP - Giappone 132
JO - Giordania 119
NG - Nigeria 62
CA - Canada 61
AR - Argentina 52
TR - Turchia 52
IQ - Iraq 39
BD - Bangladesh 38
NL - Olanda 38
CH - Svizzera 36
ID - Indonesia 34
MX - Messico 29
ZA - Sudafrica 23
BE - Belgio 21
MA - Marocco 19
UZ - Uzbekistan 19
PK - Pakistan 18
CI - Costa d'Avorio 17
ES - Italia 15
PH - Filippine 13
SA - Arabia Saudita 13
SC - Seychelles 12
CO - Colombia 11
VE - Venezuela 11
CL - Cile 9
EC - Ecuador 9
NP - Nepal 8
DZ - Algeria 7
KE - Kenya 7
NO - Norvegia 7
PE - Perù 7
TH - Thailandia 7
AT - Austria 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
LT - Lituania 6
MY - Malesia 6
OM - Oman 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
ET - Etiopia 5
JM - Giamaica 5
PT - Portogallo 5
AL - Albania 4
GE - Georgia 4
GR - Grecia 4
HU - Ungheria 4
IR - Iran 4
KG - Kirghizistan 4
LK - Sri Lanka 4
PA - Panama 4
PY - Paraguay 4
UY - Uruguay 4
BO - Bolivia 3
DK - Danimarca 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
HN - Honduras 2
KW - Kuwait 2
MN - Mongolia 2
MU - Mauritius 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BG - Bulgaria 1
Totale 30.765
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.263
Warsaw 2.684
Jacksonville 1.076
Singapore 1.066
Chandler 936
Ashburn 896
Fairfield 775
Dublin 739
Seoul 633
Hong Kong 623
San Jose 461
Woodbridge 391
Los Angeles 352
Cambridge 330
Seattle 329
Beijing 318
Wilmington 297
Houston 259
Buffalo 208
Ho Chi Minh City 200
Princeton 200
Ann Arbor 197
Boston 185
Lauterbourg 183
The Dalles 160
Hanoi 143
Melbourne 138
Boardman 131
Paris 130
New York 119
Tokyo 117
Hefei 112
Milan 94
Altamura 91
Lawrence 88
Munich 88
Council Bluffs 85
Mumbai 76
Helsinki 75
Moscow 75
Medford 73
Shanghai 73
San Diego 67
Abuja 61
Florence 58
Rome 54
Kent 48
São Paulo 47
Orem 41
Turku 37
Verona 35
Dong Ket 34
Toronto 33
Bern 31
Dallas 31
Norwalk 31
Naples 30
Frankfurt am Main 25
Haiphong 25
Da Nang 23
Izmir 22
Jakarta 22
Phoenix 22
Brooklyn 21
London 21
Redondo Beach 21
Chicago 20
Andover 19
San Francisco 19
Belo Horizonte 18
Tianjin 18
Turin 18
Abidjan 17
Brussels 17
Chennai 17
Dearborn 17
Tashkent 17
Atlanta 16
Guangzhou 16
Hillsboro 15
Rio de Janeiro 15
Ankara 14
Bologna 14
Johannesburg 14
Poplar 14
Brasília 13
Palermo 13
Yubileyny 13
Amman 12
Auburn Hills 12
Baghdad 12
Denver 12
Elk Grove Village 12
Fuzhou 11
Bari 10
Biên Hòa 10
Miami 10
Newark 10
Buenos Aires 9
Can Tho 9
Totale 19.792
Salva come PNG Salva come JPEG
Nome #
Real-time PCR analysis of RNA extracted from formalin-fixed and paraffin-embeded tissues: effects of the fixation on outcome reliability. 393
Extraventricular neurocytoma: morphological and immunohistochemical considerations on differential diagnosis. 377
Brain heterotopia in pharyngeal region. A morphological and immunohistochemicalstudy. 359
UTILIZZAZIONE DI UN DISPOSITIVO INTRAUTERINO CHE RILASCIA PROGESTERONE (PROGESTASERT) : INDICAZIONI E PROSPETTIVE 356
C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus. 349
C-KIT EXPRESSION AND CORRELATION WITH CHEMOTERAPY RESISTANCE IN OVARIAN CARCINOMA: AN IMMUNOCYTOCHEMICAL STUDY 345
EXPRESSION OF INDUCILE NITRIC OXIDE SYNTHASE AND CYCLOOXYGENASE-2 IN OVARIAN CANCER: CORRRELATION WITH CLINICAL OUTCOME 343
Oncocytic Meningioma: a case report. 338
Meningioma-primary brain lymphoma association. 334
Plasma cell granuloma--an enigmatic lesion: description of an extensiveintracranial case and review of the literature. 320
Hemangioma of the umbilical cord: report of a case. 317
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 317
Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance 306
Liquid-based endometrial cytology in the management of sonographically thickened endometrium. 303
Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women. 298
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 271
Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A. 268
Papillary glioneuronal tumor radiologically mimicking a cavernous hemangioma withhemorrhagic onset. 265
Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix. An investigation using CDX-2 and a limited immunohistochemical panel. 256
Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study. 253
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 252
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer 233
Problems of pleural cytology and histopathology 225
Endometrial adenocarcinoma. I. Histopathological findings in a series of 281 adenocarcinomas without squamous metaplasia 215
Cytodiagnosis of pleural effusions. III. Neoplastic effusions with special reference to the relationship between cytomorphology and primary site of the tumor 211
Pulmonary alveolar proteinosis. Anatomoclinical study of 3 cases followed throughout their evolution. 211
Endometrial adenocarcinoma. II. The problem of squamous metaplasia. Histopathological findings in 175 cases of adenoacanthoma and adenosquamous mixed carcinoma 207
Una rara neoplasia renale: il linfangioma cistico 195
EXPRESSION OF THE RETINOBLASTOMA-RELATED GENE RB2/P130 CORRELATES WITH CLINICAL OUTCOME IN ENDOMETRIAL CANCER 195
LA PAPILLOMATOSI DEL VESTIBOLO VULVARE. LESIONE HPV CORRELATA O VARIANTE ANATOMICA? VALUTAZIONE IMMUNOCITOCHIMICA DI 122 OSSERVAZIONI 193
HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. 190
Cerebellar liponeurocytoma: morphological, immunohistochemical, and ultrastructural study of a relapsed case 189
Clinical utility of liquid-based cytology for the characterization and management of endometrial polyps in postmenopausal age. 188
Progression markers in gynecologic (endometrial) cytology 181
Chordoid glioma: clinicopathologic profile and differential diagnosis of an uncommon tumor 181
Estrogen and progesterone receptors expression in uterine malignant smooth muscletumors: correlation with clinical outcome. 181
GIANT PELVIC RETROPERITONEAL LIPOSARCOMA 181
CAN HYSTEROSCOPIC EVALUATION OF ENDOMETRIAL CARCINOMA INFLUENCE THE THERAPEUTIC TREATMENT? 180
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study. 180
Cerebellar Lipocytoma. Case report with considerations on prognosis and management 178
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: Results of the first italian external quality assurance scheme 176
Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. 174
Hepatic alterations during Crohn's disease (author's transl) 173
A pilot study evaluating liquid-based endometrial cytology and transvaginal ultrasonography in women with postmenopausal bleeding 171
Can hysteroscopic evaluation of endometrial carcinoma influence therapeutic treatment? 171
Laser cylindrical excision for cervical adenocarcinoma in situ. 169
ANATOMIA PATOLOGICA 169
THE PROTOONCOGENE C-KIT IS EXPRESSED IN LEIOMYOSARCOMAS OF THE UTERUS 166
Cyclooxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma 165
Cerebellar liponeurocytoma: immunohistochemical and ultrastructural study of a case. 164
VULVAR CARCINOMA ASSOCIATED WITH LICHEN SCLEROSUS. EXPERIENCE AT THE FLORENCE, ITALY, VULVAR CLINIC 163
Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study. 163
Intralesional beta-interferon treatment of cervical intraepithelial neoplasia associated with human papillomavirus infection. 163
Chorangiosis: report of three cases and review of the literature. 163
Expression of metalloproteinases 2 and 9 and cyclooxygenase 2 in endometrial carcinoma. 163
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 163
hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines 162
ANALISI DELLA CORRELAZIONE TRA TLI E PARAMETRI ISTOPATOLOGICI NEL CARCINOMA DELLA CERVICE UTERINA 162
L'IPERPLASIA ENDOMETRIALE. SIGNIFICATO E LIMITI QUALE PRECURSORE DEL CARCINOMA DELL'ENDOMETRIO 162
LA TERAPIA DEL LICHEN SCLEROSO DELLA VULVA 162
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly 161
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. 161
TRATTAMENTO PROGESTINICO LOCALE DELLA IPERPLASIA ENDOMETRIALE 161
Chorion villosum does not express progesterone and estrogen receptors during the first trimester of pregnancy 158
Thin-layer cytology in endometrial diagnosis. 158
Smooth muscle cells, dendritic cells and mast cells are sources of TNFalpha and nitric oxide in human carotid artery atherosclerosis. 157
Aging of the human endometrium: peri-implantation phase endometrium does not show any age-dependent variation in lectin binding. 157
OLIGODENDROGLIOMA:CD44 AS A POSSIBLE PROGNOSTIC OPPORTUNITY 155
Ageing of the human oviduct: lectin histochemistry. 155
MORFOLOGIA DELLE LESIONI PRENEOPLASTICHE DELL'ENDOMETRIO 155
Cytopathological diagnosis in a cancer registry: a useful diagnostic tool? 152
Pineal germinoma morphological features in a liquid-based cerebrospinal fluid sample 152
Endometrial carcinoma in high-risk populations: is it time to consider a screening policy? 152
HISTOPATHOLOGIC EXAMINATION OF THE PLACENTA IN EPH GESTOSIS. ANATOMO-CLINICAL CONSIDERATION 151
Decidual pathology in the diagnosis of early spontaneous abortion 151
Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts. 151
ATLANTE DI CITOLOGIA ENDOMETRIALE 150
DNA methylation of HOXA10 in eutopic and ectopic endometrium 150
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. 149
EFFETTI CLINICI ED ISTOLOGICI DEL TRATTAMENTO TOPICO CON ESTRADIOLO NELLA DISTROFIA VULVARE 149
Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide. 148
TERAPIA INTRALESIONALE DELLE LESIONI CERVICALI DA HPV CON ß-INTERFERON 148
A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. 148
Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women. 148
HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy. 147
LA CARATTERIZZAZIONE ISTOPATOLOGICA DEI CARCINOMA DELL'OVAIO 147
ESPERIENZA CLINICA CON UN NUOVO 19-NOR-PROGESTERONE DERIVATO – NOMEGESTROLO-ACETATO – NEL TRATTAMENTO DELLA IPERPLASIA ENDOMETRIALE. 147
Cyclooxygenase-2 expression in uterine leiomyosarcomas. 146
IL NOMEGESTROLO ACETATO NEL CONTROLLO DELLA RISPOSTA ENDOMETRIALE 146
Correction: Stillbirths at term: Case control study of risk factors, growth status and placental histology (PLoS ONE (2016) 11: 12 (e0166514) DOI: 10.1371/journal.pone.0166514) 146
Atypical, anaplastic and unusual meningiomas. Morphology and incidence in 300 consecutive cases 145
Clinical and histologic effects of topical treatments of vulval lichen sclerosus.A critical evaluation. 145
Human endometrial cancers contain follicle-stimulating hormone receptors: a preliminary study. 143
Oligodendrogliomas lacking O6-methylguanine-DNA-methyltransferase expression 143
Oligodendroglioma: HMB-45 positivity using catalyzed signal amplification method: an immunohistochemical (HMB-45, CD31, p53, Mib-1) and ultrastructural study. 143
Analysis of lymphocytic infiltrate does not help in prediction of vulvar squamous cell carcinoma arising in a background of lichen sclerosus. 143
Iter diagnostico nel sanguinamento uterino anomalo: stato dell’arte, esperienza personale e proposta di approccio diagnostico. 143
Differential diagnosis between uterine carcinosarcoma versus carcinoma with sarcomatous metaplasia: an immunohistochemical and ultrastructural case study 142
Intraepithelial eosinophils in the diagnosis of reflux esophagitis 142
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 141
Totale 19.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 0 0 232
2021/20221.254 36 161 47 63 46 35 33 85 49 38 317 344
2022/20233.530 330 419 217 278 323 670 438 208 447 31 101 68
2023/20241.282 108 158 230 49 64 147 63 271 17 46 75 54
2024/20258.575 287 828 540 1.332 2.734 1.267 79 384 379 270 237 238
2025/20267.340 915 1.108 345 1.035 1.154 338 961 413 429 419 176 47
Totale 30.856